Literature DB >> 22326285

Calcineurin subunit B promotes TNF-alpha-induced apoptosis by binding to mitochondria and causing mitochondrial Ca2+ overload.

Jinbo Cheng1, Wei Tang, Zhenyi Su, Junxia Guo, Li Tong, Qun Wei.   

Abstract

Previous studies have shown that excess calcineurin subunit B (CnB) associates with mitochondria. Here, CnB overexpression increased CN activity in cells and enhanced TNF-alpha-induced cell death independent of CN activity. Overexpression of CnB increased intracellular Ca2+ concentration, enhanced caspase-3 activity, reduced Bcl-2 expression, and decreased mitochondrial membrane potential, with no change of caspase-8 or p53. CnB bound to isolated mitochondria in a Ca(2+)-dependent manner, and stimulated cytochrome c release from the mitochondria. Altogether, these results demonstrate that CnB is capable of promoting TNF-alpha-induced apoptosis, possibly through effects on mitochondrial functions.
Copyright © 2012 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22326285     DOI: 10.1016/j.canlet.2012.01.042

Source DB:  PubMed          Journal:  Cancer Lett        ISSN: 0304-3835            Impact factor:   8.679


  3 in total

1.  TNFα induces Ca2+ influx to accelerate extrinsic apoptosis in hepatocellular carcinoma cells.

Authors:  Jianjun Zhu; Mingpeng Jin; Jiaojiao Wang; Hui Zhang; Yousheng Wu; Deyang Li; Xiaoying Ji; Hushan Yang; Chun Yin; Tingting Ren; Jinliang Xing
Journal:  J Exp Clin Cancer Res       Date:  2018-03-05

2.  Cellular uptake of exogenous calcineurin B is dependent on TLR4/MD2/CD14 complexes, and CnB is an endogenous ligand of TLR4.

Authors:  Jinju Yang; Nannan Qin; Hongwei Zhang; Rui Yang; Benqiong Xiang; Qun Wei
Journal:  Sci Rep       Date:  2016-04-19       Impact factor: 4.379

3.  The genetically engineered drug rhCNB induces apoptosis via a mitochondrial route in tumor cells.

Authors:  Yang Yang; Huan Yang; Jinju Yang; Li Li; Benqiong Xiang; Qun Wei
Journal:  Oncotarget       Date:  2017-07-22
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.